Understanding Existing Antipsychotics and Newer Drug Targets in Schizophrenia

Avinash, A and Kunder, Sushil Kiran and Pathak, Anurag and Patil, Navin and Nayak, Veena (2016) Understanding Existing Antipsychotics and Newer Drug Targets in Schizophrenia. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 7 (1). pp. 1507-1520. ISSN 0975-8585

[img] PDF
160 DisplayPdf.pdf - Published Version
Restricted to Registered users only

Download (859kB) | Request a copy


Schizophrenia is a chronic, debilitating, prototypic psychotic disorder, which has antipsychotics as the mainstay of treatment. Antipsychotics are broadly divided into two: typical and atypical. While typical drugs were popular in clinical practice until a few years ago, there are slowly being replaced by the atypical drugs, mainly because of improved efficacy and lesser incidence of extra-pyramidal symptoms. However, the newer drugs have their own demerits, in the form of other adverse effects, like metabolic syndrome, QT prolongation and sudden death. Several newer targets have been identified in the field, which might help in bringing about drugs with improved efficacy and safety parameters.

Item Type: Article
Uncontrolled Keywords: Clozapine; Olanzapine; Risperidone; Quetiapine; Psychosis
Subjects: Medicine > KMC Manipal > Pharmacology
Depositing User: KMC Library
Date Deposited: 04 Feb 2016 14:37
Last Modified: 04 Feb 2016 14:37
URI: http://eprints.manipal.edu/id/eprint/145199

Actions (login required)

View Item View Item